Last reviewed · How we verify
CodaVax-H1N1 influenza vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
CodaVax-H1N1 influenza vaccine (CodaVax-H1N1 influenza vaccine) — Codagenix, Inc.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| CodaVax-H1N1 influenza vaccine TARGET | CodaVax-H1N1 influenza vaccine | Codagenix, Inc | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- CodaVax-H1N1 influenza vaccine CI watch — RSS
- CodaVax-H1N1 influenza vaccine CI watch — Atom
- CodaVax-H1N1 influenza vaccine CI watch — JSON
- CodaVax-H1N1 influenza vaccine alone — RSS
Cite this brief
Drug Landscape (2026). CodaVax-H1N1 influenza vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/codavax-h1n1-influenza-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab